Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $106.3600 (0.54%) ($104.8500 - $107.5800) on Tue. Dec. 10, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.69% (three month average) | RSI | 59 | Latest Price | $106.3600(0.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.9% a day on average for past five trading days. | Weekly Trend | LGND declines -1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) IWC(55%) XBI(55%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.345% in a week (0% probabilities). VIXM(-33%) VXX(-20%) TLT(-14%) UUP(-5%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.345% (StdDev 2.69%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
Resistance Level | $108.44 | 5 Day Moving Average | $106.53(-0.16%) | 10 Day Moving Average | $109.18(-2.58%) | 20 Day Moving Average | $108.44(-1.92%) | To recent high | -6.4% | To recent low | 17.9% | Market Cap | $1.709b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |